Copper-ionophores as a treatment for prostate cancer?

铜离子载体可以治疗前列腺癌吗？

• 批准号: nhmrc : 1027125
• 负责人: Dr Michael Cater
• 金额: $ 20.95万
• 依托单位: Deakin University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/copper-ionophores-treatment-prostate-cancer/110542
• 关键词: Copper; ionophores; treatment; prostate; cancer

The overarching aim of this project is to evaluate a potential therapy for prostate cancer, which targets a distinct characteristic of the disease 'elevated copper'. Our copper-based drugs in the laboratory selectively destroy cancerous prostate cells without harming normal cells. We will verify whether these drugs work in the body where the environment is more complex. Proof of this principle will open up a new area of research and provide a novel therapeutic approach for prostate cancer.

该项目的总体目标是评估前列腺癌的潜在治疗方法，该方法针对疾病的一个明显特征“铜升高”。我们的铜基药物在实验室中选择性地破坏癌性前列腺细胞，而不伤害正常细胞。我们将验证这些药物是否在环境更复杂的体内起作用。这一原理的证明将开辟一个新的研究领域，并为前列腺癌提供一种新的治疗方法。